• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Skip to investors navigation

Scholar Rock

Discovery and Development of Innovative Medicines

  • Careers
  • Newsroom
  • Contact Us
  • For HCPs
    • Grants and Sponsorships
    • Investigator-Initiated Studies
    • Expanded Access
    • Additional Resources and Information
    • Contact
  • Patients & Families
    • Patients & Families
    • Areas of Focus
      • Spinal Muscular Atrophy
    • Patient Stories
    • Clinical Trials
    • Resources
    • Expanded Access

    Learn about our commitment to creating possibilities for those living with serious disease.

    Patients & Families

  • Our Company
    • Our Company
    • Mission & Vision
    • Newsroom
    • Careers
      • Fellowship
    • Management Team
    • Board of Directors
    • Grants and Sponsorships
    • Investigator-Initiated Studies

    Meet Scholar Rock, a biopharmaceutical company committed to improving lives.

    Our Company

  • Our Science
    • Our Science
    • Platform
    • Publications & Posters

    Discover how our breakthrough approach treats complex disease at its biological root.

    Our Science

  • Our Pipeline
    • Our Pipeline
    • Neuromuscular
      • Spinal Muscular Atrophy
    • Cardiometabolic Disorders
    • Immuno-Oncology
      • Cancer (solid tumors)
    • Fibrotic Diseases
      • Fibrosis
    • Hematology
      • Anemia
  • Our Medicine
    • ISEMBYLD™
  • Investors & Media
    • Investor Overview
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR or Media
HomeOur CompanyCareersFellowship

Fellowship

Global Scientific Communications Fellowship Program

In partnership with
Northeastern University Pharmaceutical Industry Fellowships

View Open Fellowships

PharmD Fellowship Program

Global Scientific Communications

Actively Recruiting: 1 Fellow

Cambridge, MA

The Scholar Rock Global Scientific Communications Fellowship is a two-year program designed to provide PharmD graduates with comprehensive, hands-on training in Medical Affairs within a dynamic and innovative biopharmaceutical environment. This fellowship offers a unique opportunity to develop deep expertise in spinal muscular atrophy (SMA), a rare neuromuscular disease, while gaining exposure to Scholar Rock’s broader neuromuscular research and development portfolio. Through immersive experiences in key Medical Affairs functions–including medical communications, publications, medical information, and congress planning–the fellow will collaborate with cross-functional teams across the organization and contribute to the strategic dissemination of scientific data to healthcare professionals, researchers, and other stakeholders worldwide.

Apply for the Program

Fellowship Brochure

Footer

Scholar Rock, Inc.
301 Binney Street, 3rd Floor
Cambridge, MA 02142

Phone: 857.259.3860
[email protected]

LinkedIn X, formally Twitter

SCHOLAR ROCK and the S logo are trademarks of Scholar Rock, Inc.

© 2026 All Rights Reserved

  • Community Guidelines
  • Expanded Access
  • State Regulations & Disclosures
  • Privacy Policy
  • Terms of Use

We are Scholar Rock.

A biopharmaceutical company dedicated to discovering, developing, and delivering therapies that create new possibilities for patients.

Learn More About Our Pipeline

  • Community Guidelines
  • Expanded Access
  • State Regulations & Disclosures
  • Privacy Policy
  • Terms of Use
logo
  • Patients & Families
    • Areas of Focus
      • Spinal Muscular Atrophy
    • Patient Stories
    • Clinical Trials
    • Resources
    • Expanded Access
  • Our Company
    • Mission & Vision
    • Newsroom
    • Careers
      • Fellowship
    • Management Team
    • Board of Directors
    • Grants and Sponsorships
    • Investigator-Initiated Studies
  • Our Science
    • Platform
    • Publications & Posters
  • Our Pipeline
    • Neuromuscular
      • Spinal Muscular Atrophy
    • Cardiometabolic Disorders
    • Immuno-Oncology
      • Cancer (solid tumors)
    • Fibrotic Diseases
      • Fibrosis
    • Hematology
      • Anemia
  • Our Medicine
    • ISEMBYLD™
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR or Media
  • Careers
  • Newsroom
  • Contact Us
  • For HCPs
    • Grants and Sponsorships
    • Investigator-Initiated Studies
    • Expanded Access
    • Additional Resources and Information
    • Contact

You are now leaving the Scholar Rock website.

This external link is provided for your convenience. Scholar Rock is not responsible for content on external websites.

Continue